Bioactivity:

Ulixertinib is an inhibitor of ERK protein kinase. Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis. Upon oral administration, BVD-523 inhibits both ERK 1 and 2, thereby preventi

CAS nr:

1956366-10-1

Purity:

98%

Molecular Weight:

469,79

SMILES:

O=C(C1=CC(C2=CC(NC(C)C)=NC=C2Cl)=CN1)N[C@@H](C3=CC=CC(Cl)=C3)CO.[H]Cl

Formula:

C21H23Cl3N4O2

Pathway:

Target: